Matthew Colonnese, PhD, Seeks to Improve Diagnostic Utility of Neonatal EEGs

November 6, 2019

Researchers at the George Washington University (GW) are laying the groundwork for a future in which health care providers can more accurately diagnose brain injury and dysfunction in newborns with the use of an inexpensive and non-invasive diagnostic tool — electroencephalography (EEG).


The research, led by Matthew Colonnese, PhD, associate professor of pharmacology and physiology at the GW School of Medicine and Health Sciences, was recently funded with more than $4 million in grants from the National Eye Institute and the National Institute of Neurological Disorders and Stroke.

The researchers seek to expand current knowledge of how changes in brain connections to the cerebral cortex control the normal development of brain activity that occurs around the time of birth.

Despite more than 65 years of EEG use on newborns, understanding of rhythmic cortical activity patterns associated with brain development and injury is limited. The funding will enable the research team to help improve the interpretation and understanding of the EEG in babies, both preterm and full term.

Latest News

September 23, 2021
Celebrating the George Washington University bicentennial reflecting on the School of Medicine and Health Sciences’s (SMHS) 197 years at the university.
March 2, 2021
The George Washington University is participating in another COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites in the United States to launch a Phase II study for the Sanofi COVID-19 adjuvanted recombinant protein-based COVID-19 vaccine candidate.
February 25, 2021
The George Washington University (GW) Office of the Vice President for Research and the GW School of Medicine and Health Sciences gave COVID-19 research a shot in the arm through the FY21 COVID-19 Research Fund competition.